Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_232245868

Severe asthma patients require more support, Novartis study suggests

June 19, 2017
Research and Development, Sales and Marketing Novartis, asthma

A new study from Novartis has indicated that patients suffering from severe asthma still do not get adequate support to …

News
shutterstock_95714119

Sudanese research centre launches first-ever mycetoma trial

June 19, 2017
Research and Development, Sales and Marketing mycetoma

A significant step forward has been made in moving towards a treatment for neglected tropical disease mycetoma as the first-ever …

News

Making strides in hepatitis

June 19, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Johnson & Johnson

Pharmafocus caughtup with Lawrence Blatt, Janssen’s Global Therapeutic Area Head, Infectious Diseases and Vaccines, to discuss the progress being made in the …

Feature
mosquito

Pulses of light may offer ward against mosquitos

June 19, 2017
Research and Development, Sales and Marketing malaria, mosquito

Research emerging from scientists at the University of Notre Dame has found that exposing mosquitos to light during the night …

News
shutterstock

First-of-its-kind blood test unlocks precision treatment options for prostate cancer

June 19, 2017
Research and Development, Sales and Marketing

AstraZeneca’s Lynparza (olparib) is making yet another impact following its impressive showing this month in the ovarian cancer space, with …

News
novartis_window

Novartis receives European biosimilar approval for Roche blockbuster

June 19, 2017
Sales and Marketing Novartis, Rituxan, Rixathon, Roche

Sandoz, a division within Novartis, has received European Commission approval for its biosimilar version of Roche’s Rituxan (also known as …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 16, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

The weather is heating up as we head into summer, and another week is behind us, meaning another run-down of …

News

Shooting for the moon: The National Cancer Institute’s Formulary

June 16, 2017
Medical Communications, Research and Development NCI

Pharmafile spoke to National Cancer Institute’s (NCI) Jason Christofaro and Sherry Ansher regarding the development of an agent formulary and its role …

News
sunbathing-1207930_960_720

Drug that induces tanning could protect against melanoma

June 16, 2017
Medical Communications, Research and Development melanoma, skin cancer, sun

People will often go to extraordinary lengths to achieve tanned skin but researchers have found a potential method that does …

News
bicycle_therapeutics

Cambridge start-up secures £40 million to trial innovative cancer drugs

June 16, 2017
Medical Communications, Research and Development, Sales and Marketing Bicycle Therapeutics, Cambridge, Cancer

Bicycle Therapeutics, a biotech start-up based in Cambridge, UK, has just raised £40 million from a range of investors including …

News
fda_sign_web

New rival to EpiPen receives FDA approval to shake up market

June 16, 2017
Medical Communications, Sales and Marketing Adamis, Mylan, Symjepi, epipen

Adamis Pharmaceuticals has revealed that it received FDA approval for its EpiPen rival to enter the market. Its product, to …

News
roche__tree

From pipeline to patients: Navigating treatments through the UK system

June 15, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, pipeline

Pharmafocus spoke to Karen Lightning-Jones, Integrated Franchise Leader, Pipeline, to discuss the current UK climate for successfully developing drugs to …

Feature
aedes_aegypti_mosquito

Weakness discovered in malaria parasite could lead to new treatment

June 15, 2017
Protein, anti-malarial drug resistance, malaria, mosquito

A protein has been newly discovered that could lead to an alternative form of vaccination against the spread of malaria …

News
fda2outsideweb

FDA fast-tracks Pfizer and Lilly’s chronic pain drug

June 15, 2017
Research and Development, Sales and Marketing Eli Lilly, FDA, Pfizer

Pfizer and Eli Lilly are celebrating the FDA’s decision to grant fast-track designation to their joint venture tanezumab in the …

News
pharma_pill_manufacturing

EMA lags behind FDA on continuous manufacturing regulation

June 15, 2017
Manufacturing and Production EMA, FDA, continuous manufacturing

Continuous manufacturing is increasingly an area of fixation within the pharma industry for the benefits it can bring to the …

News

Novartis’ Cosentyx shines in ankylosing spondylitis and psoriatic arthritis

June 15, 2017
Research and Development Cosentyx, Novartis

Novartis has released new data on the efficacy of its drug Cosentyx (secukinumab) in the treatment of life-long inflammatory diseases …

News
microscope-275984_960_720

LifeArc rebrands and sets up £500m research fund

June 15, 2017
Medical Communications, Research and Development, Sales and Marketing LifeArc, MRC Technology, keytruda

The UK medical research charity formerly known as MRC Technology has rebranded to be known as LifeArc. At the same …

News
credit-_pdxnative

Trump appoints new Director of the National Cancer Institute

June 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing National Cancer Institute, appointment

Dr Norman Sharpless has been named as Director of the National Cancer Institute (NCI), part of the National Institutes of …

Appointment

PrimeVigilance is committed to minimising the impact of UK’s Withdrawal from the EU

June 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, primevigilance

Guildford, UK 14th  June, 2017

News
Press release
1491927276280

Alexion secures ex-Biogen Chief Financial Officer

June 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, Biogen, appointment

Alexion Pharmaceuticals has announced that it has snatched up Biogen’s long-serving Chief Financial Officer Paul Clancy and will instate him …

Appointment
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026